- Is PROS Inherited?
- 6 Types of PROS
-
Comments
-
**COMMENTSTAGLIST**
-
More
-
**OTHERTAGLIST**
PIK3CA-related overgrowth spectrum (PROS), also called PIK3CA-associated segmental overgrowth, is a group of rare genetic conditions characterized by the overgrowth of body tissues. The various conditions under PROS result from mutations (abnormal changes) in the PIK3CA gene.
The defective PIK3CA gene could be present in some or all cells of the affected individual. The presence of a mixed population of cells where some are mutated PIK3CA genes while others have normal PIK3CA genes is called mosaicism.
- Mosaicism is typically not passed on to the next generation (not inherited).
- Rarely, a PIK3CA mutation in the germline cells (eggs or sperms) may affect all the cells in the body.
Is PIK3CA-related overgrowth spectrum (PROS) inherited?
Presently, there are no known cases of inherited PIK3CA-related overgrowth spectrum (PROS). None of the studies have suggested the parent-to-child transmission of PROS. There are no reports of the condition in siblings of the affected person.
Most PROS cases have a somatic mutation, which is a genetic defect that is not inherited. These mutations occur randomly after fertilization (fusion of egg with sperm) and affect the somatic cells that are cells other than the gametes (egg and sperm). The random mutations result in a mixed population of normal and abnormal cells (mosaicism).
In rare cases, PROS could be associated with mutations in the germ cells or gametes (germline mutations). These germline mutations are not inherited from parents. Rather, they occur on their own in the affected person (de novo mutations). A person with a germline mutation in the PIK3CA gene has a 50 percent likelihood of passing the disease to their child. As already stated, no such cases of inherited PROS have been reported so far.
What are the types of PIK3CA-related overgrowth spectrum (PROS)?
PIK3CA-related overgrowth spectrum (PROS) can cause various health conditions including:
- Fibroadipose hyperplasia (FH):
- Also called fibro adipose overgrowth, FH causes a patchy overgrowth of any limb or body part due to excessive growth of fatty or fibrous tissue, with or without excessive blood vessels formation.
- The condition is generally not identifiable at birth and typically worsens with time.
- CLOVES syndrome:
- Also called congenital lipomatous overgrowth syndrome, this condition is identifiable right at birth (congenital).
- It is characterized by the following:
- Megalencephaly-capillary malformation syndrome (MCAP syndrome):
- Also called macrocephaly-cutis marmorata telangiectatica congenita syndrome (M-CMTC), the condition is characterized by a large brain (megalencephaly) that leads to large head size (macrocephaly).
- Various abnormal capillaries or tiny blood vessels in the skin cause the appearance of pink to red-colored skin patches.
- Hemihyperplasia-multiple lipomatosis syndrome (HHML syndrome):
- The condition causes asymmetric, nonprogressive overgrowth of the limbs.
- Several fatty or lipomatous masses may develop under the skin throughout the body. This especially affects the back, torso, limbs, underarms, and fingers.
- These lipomatous masses are typically slow-growing and painless.
- HHML can increase the risk of certain abdominal cancers.
- Hemimegalencephaly:
- There is an asymmetric overgrowth of the brain and generally involves one side of the brain.
- This leads to an asymmetric head coupled with problems, such as seizures and learning difficulties.
- Facial infiltrating lipomatosis:
SLIDESHOW
See SlideshowMorgan KK. What Is PIK3CA-Related Overgrowth Spectrum (PROS)? WebMD. https://www.webmd.com/a-to-z-guides/what-is-pros
National Organization for Rare Disorders. NIH GARD Information: PIK3CA-related overgrowth spectrum. https://rarediseases.org/gard-rare-disease/pik3ca-related-overgrowth-spectrum/
Genetic and Rare Diseases Information Center. Megalencephaly-capillary malformation syndrome. https://rarediseases.info.nih.gov/diseases/6950/macrocephaly-capillary-malformation
U.S. National Institutes of Health. A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006). https://clinicaltrials.gov/ct2/show/NCT04980872
Top What is PIK3CA-related overgrowth spectrum (PROS) Related Articles
Cancer
Cancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.Family Health History: Genetics, DNA Testing and Your Health
WebMD explains why your doctor asks about your relatives' health conditions and how you can get the information if you don’t know.Genetic Diseases
The definition of a genetic disease is a disorder or condition caused by abnormalities in a person's genome. Some types of genetic inheritance include single inheritance, including cystic fibrosis, sickle cell anemia, Marfan syndrome, and hemochromatosis. Other types of genetic diseases include multifactorial inheritance. Still other types of genetic diseases include chromosome abnormalities (for example, Turner syndrome, and Klinefelter syndrome), and mitochondrial inheritance (for example, epilepsy and dementia).Genetic Testing: Families With Breast Cancer
Breast cancer can be a killer and the decision to get tested to see if a patient is prone to the disease should be discussed with a doctor -- particularly if the woman has a history of breast cancer in her family. Genetic testing can only tell so much about breast cancer risk, however.How Is PIK3CA Mutation Treated?
The FDA approved the drug Piqray (alpelisib) for the treatment of PIK3CA mutations associated with advanced breast cancer. Learn about PIK3CA mutation and Piqray drug side effects.Vijoice (alpelisib)
Vijoice (alpelisib) is a prescription medication used to treat the symptoms of breast cancer and severe manifestations of PIK3CA-related overgrowth spectrum (PROS) in adults and children 2 years of age and older who require systemic therapy. Vijoice may cause serious side effects, including hives, difficulty breathing, swelling of your face/lips/tongue/throat, chest pain, cough, shortness of breath, severe or ongoing diarrhea, blisters or ulcers in your mouth, red or swollen gums, trouble swallowing, pale skin, unusual tiredness, cold hands and feet, little or no urination, increased thirst, increased urination, and others. Vijoice can cause fetal harm when administered to a pregnant woman. Lactating women should not breastfeed during treatment with Vijoice.